|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.680 USD | -0.62% |
|
+0.73% | +57.40% |
| 15/05 | ImmuCell Corporation, Q1 2026 Earnings Call, May 15, 2026 | |
| 15/05 | ImmuCell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Scours | - | 1.84Cr | 1.73Cr | 2.63Cr | 2.74Cr | |||||
Total Assets | - | 2.05Cr | 2.47Cr | 2.46Cr | 3.82Cr | |||||
CAPEX | - | -35.13L | -10.97L | -4L | -11.68L | |||||
Gross Profit | - | 76.58L | 38.4L | 79.31L | 1.14Cr | |||||
D&A | - | 11.69L | 13.66L | 13.74L | 14.58L | |||||
Operating Income | - | 57.19L | 13.82L | 47.78L | 78.9L | |||||
Mastitis | - | 2L | 2L | 2L | 2L | |||||
Total Assets | - | 1.83Cr | 1.78Cr | 1.65Cr | 1L | |||||
CAPEX | - | -4L | -8L | -53.72T | -74.88T | |||||
Gross Profit | - | 18.21T | 28.86T | 9.74T | 27.26T | |||||
D&A | - | 12.63L | 12.88L | 12.77L | 12.57L | |||||
Operating Income | - | -56.18L | -48.55L | -40.4L | -29.21L | |||||
Biotechnology | 1.92Cr | - | - | - | - | |||||
Total Assets | 4.45Cr | - | - | - | - | |||||
Interest Expense | -3L | - | - | - | - | |||||
Income Tax Expense | 9.16T | - | - | - | - | |||||
CAPEX | -26.09L | - | - | - | - | |||||
EBT | -69.13T | - | - | - | - | |||||
Gross Profit | 86.56L | - | - | - | - | |||||
D&A | 24.61L | - | - | - | - | |||||
Operating Income | 3L | - | - | - | - | |||||
Net Income | -78.29T | - | - | - | - | |||||
Other | - | 1.46T | - | - | - | |||||
Total Assets | - | 60.06L | 12.45L | 39.33L | 41.53L | |||||
CAPEX | - | -47.45T | - | -2.31T | -7.13T | |||||
Gross Profit | - | -27.19T | - | - | - | |||||
D&A | - | 62.91T | 86.03T | 78.81T | 69.25T | |||||
Operating Income | - | -24.01L | -22.76L | -23.78L | -33.2L |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 1.66Cr | 1.7Cr | 1.59Cr | 2.29Cr | 2.44Cr | |||||
Other | 26.23L | 15.47L | 15.22L | 35.99L | 32.53L |
- Stock Market
- Stocks
- ICCC Stock
- Financials ImmuCell Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
